tumor tissues
NCI-H660; LNCaP; VCaP
-
not specified
RNA-seq; RT-qPCR; RNase R Treatment; Clinical Sample Validation
Potential surrogate marker to distinguish neuroendocrine prostate cancer subtype.
circ-AURKA is significantly up-regulated in neuroendocrine prostate cancer compared with CRPC. Its circular structure and backsplice (exon 6 to exon 3) were confirmed by RT-qPCR after RNase R treatment, and it shows higher expression in the NEPC cell line NCI-H660 than in non-NEPC prostate cancer cell lines.
0.4773
The Landscape of Circular RNA in Cancer.
combined biological and clinical study